Filing Details
- Accession Number:
- 0001333277-19-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-24 08:56:10
- Reporting Period:
- 2019-09-20
- Accepted Time:
- 2019-09-24 08:56:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042074 | Cymabay Therapeutics Inc. | CBAY | Pharmaceutical Preparations (2834) | 943103561 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588861 | Sujal Shah | C/O Cymabay Therapeutics, Inc. 7575 Gateway Boulevard, Suite 110 Newark CA 94560 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-20 | 1,900 | $5.50 | 111,900 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-23 | 3,100 | $5.55 | 115,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
